Reviewing Rejuvel Bio-Sciences (OTCMKTS:NUUU) and Vestis (NYSE:VSTS)

Rejuvel Bio-Sciences (OTCMKTS:NUUU) and Vestis (NYSE:VSTS) are both consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Risk and Volatility

Rejuvel Bio-Sciences has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Vestis has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500.

Valuation and Earnings

This table compares Rejuvel Bio-Sciences and Vestis”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rejuvel Bio-Sciences	N/A	N/A	N/A	N/A	N/A
Vestis	$2.81 billion	0.77	$20.97 million	$0.16	102.48

Vestis has higher revenue and earnings than Rejuvel Bio-Sciences.

Institutional & Insider Ownership

97.4% of Vestis shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Rejuvel Bio-Sciences and Vestis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rejuvel Bio-Sciences	N/A	N/A	N/A
Vestis	0.75%	9.07%	2.65%

Analyst Ratings

This is a summary of current ratings and price targets for Rejuvel Bio-Sciences and Vestis, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rejuvel Bio-Sciences	0	0	0	0	0.00
Vestis	1	7	2	0	2.10

Vestis has a consensus target price of $16.91, indicating a potential upside of 3.17%. Given Vestis’ stronger consensus rating and higher probable upside, analysts plainly believe Vestis is more favorable than Rejuvel Bio-Sciences.

Summary

Vestis beats Rejuvel Bio-Sciences on 9 of the 9 factors compared between the two stocks.

About Rejuvel Bio-Sciences

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.

About Vestis

Vestis Corporation provides uniform rentals and workplace supplies in the United States and Canada. Its products include uniform options, such as shirts, pants, outerwear, gowns, scrubs, high visibility garments, particulate-free garments, and flame-resistant garments, as well as shoes and accessories; and workplace supplies, including managed restroom supply services, first-aid supplies and safety products, floor mats, towels, and linens. The company serves manufacturing, hospitality, retail, food processing, food service, pharmaceuticals, healthcare, automotive, and cleanroom industries. Vestis Corporation was founded in 1936 and is headquartered in Roswell, Georgia.